Lv1
20 积分 2025-09-07 加入
A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia
29天前
已完结
Efficacy of CD38 ‐Targeted Therapy in Severe, Multi‐Agent Refractory Immune Thrombocytopenia: A Case Series
1个月前
已完结
Daratumumab in patients with immune thrombocytopenia: a single-center, open-label, phase 2 trial
1个月前
已完结
Long‐term complete remissions of refractory severe idiopathic immune thrombocytopenia treated with daratumumab: A case series
3个月前
已完结
Daratumumab as a novel treatment option in refractory ITP
3个月前
已完结
The early and rapid response to daratumumab in children with chronic refractory immune thrombocytopenia from a referral single centre of China
3个月前
已完结
Daratumumab in Relapsed or Refractory Pediatric Immune Thrombocytopenia
3个月前
已完结
Hepatitis B reactivation in patients with multiple myeloma treated with anti-CD38 monoclonal antibody-based therapies: a pharmacovigilance analysis
3个月前
已完结
Hepatitis B virus reactivation in a myeloma patient with resolved infection who received daratumumab-containing salvage chemotherapy
3个月前
已关闭
Reactivation of Resolved Hepatitis B After Daratumumab for Multiple Myeloma
3个月前
已关闭
皖公网安备34019202002308
